Consistent with our computational analysis, Clec4d−/− mice38 receiving anti-PD-1 treatment showed no significant reduction in tumor burden compared with Clec4d−/− mice receiving IgG control, whereas the treatment can inhibit tumor development in groups of WT mice (Fig. 6a–c). This evidence concerns the gene PDCD1 and neoplasm.